Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
84 Results Found
HRSA Finalizes 340B Administrative Dispute Resolution Process
The Department of Health and Human Services (HHS) and the Health Resources and Services Administration (HRSA) April 19 published the 340B Administrative Dispute Resolution (ADR) final rule establishing a process that was required under the Affordable Care Act.
AHA Statement on “Health Care Spending in the United States: Unsustainable for Patients, Employers, and Taxpayers”
The AHA shares comments on the topic of national health expenditures before the House Committee on Energy and Commerce Subcommittee on Health .
AHA Comments on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act
AHA comments on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
Affordability Advocacy Agenda
Our shared focus with Congress and Administration is on providing relief from the pandemic, ensuring a smooth recovery, and rebuilding a better health care system for the future. The American Hospital Association continues to incorporate principles that promote improved affordability, value, and equity into our policy and advocacy activities.
High & Rising Drug Prices: Myth vs. Fact
Get the facts on 8 common misconceptions about the rising costs of prescription drugs.
CMS to Reduce Medicare Coinsurance for 27 Part B Drugs, Starting April 1
The Centers for Medicare and Medicaid Services (CMS) March 15 announced 27 prescription drugs for which it will lower Part B beneficiary coinsurance, beginning April 1 through June 30, 2023, as required by the Inflation Reduction Act (IRA).
Drug Prices
Hospitals bear a heavy financial burden when the cost of drugs increases. They are not only major purchasers of drugs, but patients often end up in the hospital when they cannot afford to take their medications as prescribed. To that end, the American Hospital Association is proud to be a member of the Campaign for Sustainable Rx Pricing -– a diverse coalition of doctors, hospitals, pharmacists, employers, health plans, seniors, patients, consumers and others coming together to find common ground and solutions.
CMS Issues Proposed Rule for CY 2024 Medicare Advantage, Prescription Drug Plans
The Centers for Medicare & Medicaid Services (CMS) Dec. 14 released its proposed Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Program for Contract Year (CY) 2024. The proposed rule would increase oversight of Medicare Advantage (MA) plans and better align them with Traditional Medicare, address access gaps in behavioral health services and further streamline prior authorization processes, supplementing a separate proposal last week.
AHA Comments to MedPAC Re: Topics to be Discussed at the Commissioner’s September Meeting
AHA comments to MedPAC regarding topics to be discussed at the commissioner’s September meeting.
Fact Sheet: Advocacy Priorities for Fall 2022
America’s hospitals and health systems continue to deal with the difficult challenges of high inflation and ongoing effects of the COVID-19 pandemic. Specifically, hospitals are facing significant increases in costs of labor from workforce shortages, drugs, equipment and supplies (including food and energy costs) that are threatening their stability and ability to provide access to high quality health care services. The AHA has developed resources that hospital leaders can use to advocate on these important issues.